MAHAFFY PATRICK J
Insider CIK 1266569 · OREX Director · FLXN Director · CLVS See Remarks, Director · MDCX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MDCX Medicus Pharma Ltd. | A Award deriv | 2026-06-03 | 2026-06-04 | 50,000 | — | $0 | 50,000 | SEC↗ |
| MDCX Medicus Pharma Ltd. | A Award deriv | 2026-03-30 | 2026-04-01 | 25,000 | — | $0 | 25,000 | SEC↗ |
| MDCX Medicus Pharma Ltd. | A Award deriv | 2025-12-16 | 2025-12-18 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2022-03-01 | 2022-03-03 | 80,000 | — | $0 | 80,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2022-03-01 | 2022-03-03 | 220,000 | — | $0 | 220,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2022-03-01 | 2022-03-03 | 80,000 | — | $0 | 80,000 | SEC↗ |
| FLXN Flexion Therapeutics Inc | D To issuer deriv | 2021-11-19 | 2021-11-19 | 18,000 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | D To issuer deriv | 2021-11-19 | 2021-11-19 | 12,500 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | D To issuer deriv | 2021-11-19 | 2021-11-19 | 18,000 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | D To issuer deriv | 2021-11-19 | 2021-11-19 | 18,000 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | D To issuer deriv | 2021-11-19 | 2021-11-19 | 12,500 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | D To issuer deriv | 2021-11-19 | 2021-11-19 | 18,000 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | D To issuer deriv | 2021-11-19 | 2021-11-19 | 18,000 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | D To issuer deriv | 2021-11-19 | 2021-11-19 | 18,000 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | D To issuer | 2021-11-19 | 2021-11-19 | 39,824 | $8.50 | $338.5K | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award deriv | 2021-06-24 | 2021-06-28 | 12,500 | — | $0 | 12,500 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award | 2021-06-24 | 2021-06-28 | 4,500 | — | $0 | 39,824 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2021-03-01 | 2021-03-03 | 40,000 | — | $0 | 40,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2021-03-01 | 2021-03-03 | 40,000 | — | $0 | 40,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2021-03-01 | 2021-03-03 | 220,000 | — | $0 | 220,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2021-03-01 | 2021-03-03 | 80,000 | — | $0 | 80,000 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award deriv | 2020-06-10 | 2020-06-12 | 12,500 | — | $0 | 12,500 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award | 2020-06-10 | 2020-06-12 | 4,500 | — | $0 | 35,324 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2020-02-13 | 2020-02-18 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2020-02-03 | 2020-02-03 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2020-02-03 | 2020-02-03 | 200,000 | — | $0 | 200,000 | SEC↗ |
| FLXN Flexion Therapeutics Inc | M Exercise deriv | 2019-08-29 | 2019-08-29 | 30,824 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | M Exercise | 2019-08-29 | 2019-08-29 | 30,824 | $0.16 | $4.9K | 30,824 | SEC↗ |
| CLVS Clovis Oncology, Inc. | P Buy | 2019-08-16 | 2019-08-19 | 5,100 | $5.60 | $28.6K | 962,960 | SEC↗ |
| CLVS Clovis Oncology, Inc. | P Buy | 2019-08-16 | 2019-08-19 | 5,827 | $5.60 | $32.6K | 968,787 | SEC↗ |
| CLVS Clovis Oncology, Inc. | P Buy | 2019-08-16 | 2019-08-19 | 400 | $5.56 | $2.2K | 919,187 | SEC↗ |
| CLVS Clovis Oncology, Inc. | P Buy | 2019-08-16 | 2019-08-19 | 400 | $5.58 | $2.2K | 919,587 | SEC↗ |
| CLVS Clovis Oncology, Inc. | P Buy | 2019-08-16 | 2019-08-19 | 3,706 | $5.57 | $20.6K | 923,293 | SEC↗ |
| CLVS Clovis Oncology, Inc. | P Buy | 2019-08-16 | 2019-08-19 | 2,100 | $5.61 | $11.8K | 925,393 | SEC↗ |
| CLVS Clovis Oncology, Inc. | P Buy | 2019-08-16 | 2019-08-19 | 11,053 | $5.59 | $61.8K | 957,860 | SEC↗ |
| CLVS Clovis Oncology, Inc. | P Buy | 2019-08-16 | 2019-08-19 | 6,400 | $5.61 | $35.9K | 931,793 | SEC↗ |
| CLVS Clovis Oncology, Inc. | P Buy | 2019-08-16 | 2019-08-19 | 11,314 | $5.58 | $63.1K | 943,107 | SEC↗ |
| CLVS Clovis Oncology, Inc. | P Buy | 2019-08-16 | 2019-08-19 | 3,700 | $5.59 | $20.7K | 946,807 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award deriv | 2019-06-19 | 2019-06-21 | 18,000 | — | $0 | 18,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2019-02-01 | 2019-02-04 | 200,000 | — | $0 | 200,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2019-02-01 | 2019-02-04 | 100,000 | — | $0 | 100,000 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award deriv | 2018-06-20 | 2018-06-21 | 18,000 | — | $0 | 18,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2018-03-01 | 2018-03-02 | 120,000 | — | $0 | 120,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2017-07-14 | 2017-07-18 | 5,000 | — | $0 | 5,000 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award deriv | 2017-06-22 | 2017-07-27 | 18,000 | — | $0 | 18,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2017-03-27 | 2017-03-28 | 150,000 | — | $0 | 150,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | J Other deriv | 2016-09-16 | 2016-09-19 | 25,000 | — | $0 | 75,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2016-07-12 | 2016-07-14 | 15,000 | — | $0 | 15,000 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award deriv | 2016-06-10 | 2016-06-13 | 18,000 | — | $0 | 18,000 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award deriv | 2016-06-10 | 2016-06-22 | 18,000 | — | $0 | 18,000 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award deriv | 2015-06-17 | 2015-06-19 | 18,000 | — | $0 | 18,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2015-06-09 | 2015-06-10 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2015-03-02 | 2015-03-04 | 100,000 | — | $0 | 100,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2014-06-27 | 2014-06-27 | 50,000 | — | $0 | 50,000 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award deriv | 2014-03-03 | 2014-03-04 | 18,000 | — | $0 | 18,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2014-01-10 | 2014-01-14 | 200,000 | — | $0 | 200,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2013-06-05 | 2013-06-07 | 35,000 | — | $0 | 35,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2013-03-01 | 2013-03-04 | 200,000 | — | $0 | 200,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2012-06-07 | 2012-06-11 | 35,000 | — | $0 | 35,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2012-03-01 | 2012-03-05 | 150,000 | — | $0 | 150,000 | SEC↗ |